Clinical trial
Bioequivalence of Extended Release Nifedipine Tablets in Healthy Chinese Subjects: A Single-dose and Two-period Crossover Study
NCT04438720 is registered in ClinicalTrials.gov with Cao Yu as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Bioequivalence of Extended Release Nifedipine Tablets in Healthy Chinese Subjects: A Single-dose and Two-period Crossover Study
- Lead sponsor
- Cao Yu
- Phase
- Phase 1
- Overall status
- Unknown status
- Start date
- June 25, 2020
- Completion date
- September 30, 2020
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
therapeutic equivalency